SUFU 2018: Randomized Controlled Trial of Group-Administered Behavioral Treatment in Reducing Urinary Incontinence in Adult Women

Austin, TX (UroToday.com) Dr. Diane Newman and colleagues presented a randomized controlled trial of 463 women ages 55 and older, to determine the effectiveness of Group Behavioral Therapy (GBT) versus no treatment in adult women with no prior treatments, with stress, urgency, or mixed urinary incontinence.  The patients were randomized to a GBT group and a no treatment group.  The authors looked at the results of the ICIQ UI-SF scores, as well as a 3-day voiding diary, paper towel test, 24-hr pad weight, Brink test, Incontinence Quality of Life Questionnaire (I-QOL) and Patient Global Impression of Improvement (PGI-I).  The women undergoing GBT attended a one time 2 hour bladder health class, both groups received a behavioral education brochure.  The follow ups were every 3 months for 1 year, with clinic visits at months 3 and 12, with mailed questionnaires at months 6 and 9.

The authors found the data supported favored the GBT group, with ICIQ-UI SF (p<0.0001), average number of voids/day (p=<0.0002) and leaks/day (p=0.0002) on a voiding diary, paper towel test (p =0.0008), 24-hr pad weights (p=0.0007), Medical, Epidemiologic & Social aspects of Aging questionnaire (MESA) (p<0.0001), Incontinence Quality of Life (IQOL) (p<0.0001) & PGI-I (p<0.0001) but not the Brink test for pelvic floor strength (p=0.09). 

The authors conclude that Group Behavioral Therapy used in the context of bladder management is effective to improve incontinence symptoms and quality of life in older women with urinary incontinence. 
 

Source of Funding: NIH/NIA # RO1AG043383
ClinicalTrials.gov Identifier: NCT02001714

Presented by: Diane Newman, DNP, ANP-BC¹

Co-Authors: Ananias Diokno MD², Kathyrn Burgio PhD³, Lisa Low PhD RN⁴, Tomas Griebling MD⁵, Michael Maddens MD², Leslee Subak MD⁶, Patricia Goode MD³, Carolyn Sampselle PhD⁴, Ann Robinson RN⁷, Trevillore Raghunathan PhD⁴, Judy Boura MS⁷, Donna Mcintyre MS⁷, Alesandra Magno BS⁸ and Hanna Stambakio BS⁸

Author Information: 
1. Division of Urology, University of Pennsylvania
2. Oakland University, Royal Oak, MI
3. University of Alabama, Birmingham, AL
4. University of Michigan, Ann Arbor, MI
5. University of Kansda, Kansas City, KS
6. Stanford Univ, Palo Alto, CA
7. Beaumont Hosp, Royal Oak, MI
8. Urology, University of Pennsylvania, Phila, PA

Written by: Cristina Palmer, DO. Female Urology, Pelvic Reconstruction, Voiding Dysfunction Fellow, Department of Urology, UC Irvine Medical Center, Orange, California at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction Winter Meeting (SUFU 2018), February 27-March 3, 2018, Austin, Texas
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe